COUNTERPOINT: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients

Though LHRH agonists may be the preferred method of ovarian function suppression, ovarian ablation is a viable option for select premenopausal breast cancer patients.

Source: CancerNetwork - April 15, 2018 Category: Cancer & Oncology Authors: Ann H. Partridge, MD, MPH Philip D. Poorvu, MD Tags: Breast Cancer Oncology Journal Source Type: news